{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:03:16Z","timestamp":1791385396433,"version":"4.3.3"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603339"],"award-info":[{"award-number":["81603339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602344"],"award-info":[{"award-number":["81602344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1708085QH175"],"award-info":[{"award-number":["1708085QH175"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18CDA34110359"],"award-info":[{"award-number":["18CDA34110359"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.phrs.2018.11.006","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T11:58:51Z","timestamp":1541419131000},"page":"62-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"C","title":["Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potential"],"prefix":"10.1016","volume":"139","author":[{"given":"Xiaojun","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0335-3835","authenticated-orcid":false,"given":"Peter J.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-5217","authenticated-orcid":false,"given":"Suo-wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0005","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.7150\/thno.21966","article-title":"Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects","volume":"8","author":"Xu","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.phrs.2018.11.006_bib0010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/med.21300","article-title":"Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications","volume":"34","author":"Xu","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2018.11.006_bib0015","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the american heart association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.phrs.2018.11.006_bib0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European society of cardiology: cardiovascular disease statistics 2017","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2018.11.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2018.04.007","article-title":"Atherosclerosis is an epigenetic disease","author":"Xu","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/med.21438","article-title":"Atheroprotective effects and molecular targets of tanshinones derived from herbal medicine danshen","volume":"38","author":"Fang","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2018.11.006_bib0035","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events","volume":"12","author":"Squizzato","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2018.11.006_bib0040","article-title":"Perioperative beta-blockers for preventing surgery-related mortality and morbidity","volume":"3","author":"Blessberger","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2018.11.006_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175947","article-title":"Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015: a systematic review and meta-analysis","volume":"12","author":"Zhao","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0050","doi-asserted-by":"crossref","first-page":"15427","DOI":"10.1038\/s41598-017-14692-3","article-title":"Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection","volume":"7","author":"Lyu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.11.006_bib0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fphar.2017.00361","article-title":"Specific combination of salvianolic acids As core active ingredients of Danhong injection for treatment of arterial thrombosis and its derived dry gangrene","volume":"8","author":"Zhao","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2018.11.006_bib0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fphar.2018.00550","article-title":"The therapeutic efficacy of Danhong injection combined with percutaneous coronary intervention in acute coronary syndrome: a systematic review and meta-analysis","volume":"9","author":"Zou","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2018.11.006_bib0065","article-title":"Postmarketing safety surveillance and reevaluation of Danhong injection: clinical study of 30888 cases","volume":"2015","author":"Li","year":"2015","journal-title":"Evid. Complement. Alternat. Med."},{"key":"10.1016\/j.phrs.2018.11.006_bib0070","unstructured":"D.Y. Guo, Yi Zhong Danhong Zhu She Ye de Zhi Bei Fang Fa Ji Qi Chan Ping. China Patent CN101002828 filed January 10, 2007, and issued July 25, 2007."},{"key":"10.1016\/j.phrs.2018.11.006_bib0075","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3389\/fphar.2017.00833","article-title":"A comprehensive strategy to evaluate compatible stability of chinese medicine injection and infusion solutions based on chemical analysis and bioactivity assay","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2018.11.006_bib0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.041","article-title":"Cardiovascular actions and therapeutic potential of tanshinone IIA","volume":"220","author":"Gao","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.phrs.2018.11.006_bib0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/13543776.2013.743995","article-title":"Tanshinone II-A: new perspectives for old remedies","volume":"23","author":"Xu","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.phrs.2018.11.006_bib0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpba.2018.04.043","article-title":"Multiple on-line screening and identification methods for hydroxyl radical scavengers in Yudanshen","volume":"156","author":"Wang","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0100","doi-asserted-by":"crossref","first-page":"e110124","DOI":"10.1371\/journal.pone.0110124","article-title":"Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1743-7075-10-68","article-title":"Activation of transsulfuration pathway by salvianolic acid a treatment: a homocysteine-lowering approach with beneficial effects on redox homeostasis in high-fat diet-induced hyperlipidemic rats","volume":"10","author":"Zhang","year":"2013","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.phrs.2018.11.006_bib0110","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.freeradbiomed.2018.06.035","article-title":"Cerebroprotection by salvianolic acid B after experimental subarachnoid hemorrhage occurs via Nrf2- and SIRT1-dependent pathways","volume":"124","author":"Zhang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2018.11.006_bib0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-018-0026-6","article-title":"Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-kappaB and p38 MAPK signaling pathways in 5\/6 nephrectomized rats","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"06","key":"10.1016\/j.phrs.2018.11.006_bib0120","first-page":"109","article-title":"Research progress in pharmacological action of honghua injection","volume":"39","author":"Wan","year":"2011","journal-title":"Zhong Yi Yao Xue Bao"},{"issue":"01","key":"10.1016\/j.phrs.2018.11.006_bib0125","first-page":"68","article-title":"Clinical application of Honghua injection","volume":"34","author":"Hu","year":"2017","journal-title":"Hu Bei Min Zu Xue Yuan Xue Bao"},{"issue":"07","key":"10.1016\/j.phrs.2018.11.006_bib0130","first-page":"1158","article-title":"Determination of active ingredients in Honghua injection and comparison of dose-effect relationship among different manufacturers","volume":"32","author":"Liu","year":"2012","journal-title":"Yao Wu Fen Xi Za Zhi"},{"key":"10.1016\/j.phrs.2018.11.006_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2018.07.020","article-title":"Dose-dependent target diversion of Danhong injection on the Glu-GLT-1\/Gly-GlyRalpha dynamic balance module of cerebral ischemia","author":"Xu","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"15","key":"10.1016\/j.phrs.2018.11.006_bib0140","first-page":"1435","article-title":"Comparative analysis of main shared substances in Danhong injection, Danshen injection and Honghua injection","volume":"37","author":"Zhang","year":"2017","journal-title":"Zhong Guo Yi Yuan Yao Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.phrs.2018.11.006_bib0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/dmd.114.061473","article-title":"Systemic exposure to and disposition of catechols derived from Salvia miltiorrhiza roots (Danshen) after intravenous dosing DanHong injection in human subjects, rats, and dogs","volume":"43","author":"Li","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"93","key":"10.1016\/j.phrs.2018.11.006_bib0150","first-page":"18354","article-title":"Clinical rational application of Danhong injection in the treatment of stroke cardio-cerebral vascular disease","volume":"4","author":"Ding","year":"2017","journal-title":"Lin Chuang Yi Yao Wen Xian Dian Zi Za Zhi"},{"issue":"30","key":"10.1016\/j.phrs.2018.11.006_bib0155","first-page":"51","article-title":"Clinical rational application of Danhong injection in the treatment of stroke cardio-cerebral vascular disease","volume":"5","author":"Bai","year":"2017","journal-title":"Zhong Xi Yi Jie He Xin Xue Guan Bing Dan Zi Za Zhi"},{"issue":"03","key":"10.1016\/j.phrs.2018.11.006_bib0160","first-page":"441","article-title":"Therapeutic effect of Danhong injection combined with sodium ozagrel in the treatment of senile cerebral infarction complicated with hypertension","volume":"39","author":"Hua","year":"2016","journal-title":"Yao Wu Ping Jia Yan Jiu"},{"issue":"02","key":"10.1016\/j.phrs.2018.11.006_bib0165","article-title":"Effect of Danhong injection combined with isosorbide mononitrate on coronary heart disease","volume":"34","author":"Su","year":"2018","journal-title":"Zhong Guo She Qu Yi Shi"},{"issue":"22","key":"10.1016\/j.phrs.2018.11.006_bib0170","first-page":"109","article-title":"Clinical observation of Danhong injection combined with shexiang baoxin pill in treating angina pectoris of coronary heart disease","volume":"9","author":"Liu","year":"2017","journal-title":"Zhong Yi Lin Chuang Yan Jiu"},{"issue":"06","key":"10.1016\/j.phrs.2018.11.006_bib0175","first-page":"643","article-title":"Therapeutic effect of integrated traditional Chinese and Western medicine on coronary heart disease with angina pectoris","volume":"33","author":"Ren","year":"2017","journal-title":"Shi Yong Zhong Yi Yao Za Zhi"},{"issue":"03","key":"10.1016\/j.phrs.2018.11.006_bib0180","first-page":"321","article-title":"Therapeutic effect of Wenxin granule combined with Danhong injection on coronary heart disease with angina pectoris and its effect on CRP and hemorheology","volume":"23","author":"Chen","year":"2016","journal-title":"Zhong Guo Zhong Yi Yao Ke Ji"},{"issue":"01","key":"10.1016\/j.phrs.2018.11.006_bib0185","first-page":"21","article-title":"Effect of Danhong injection on coronary atherosclerotic heart disease and blood lipid rheology","volume":"6","author":"Gao","year":"2018","journal-title":"Zhong Xi Yi Jie He Xin Xue Guan Bing Dian Zi Za Zhi"},{"issue":"01","key":"10.1016\/j.phrs.2018.11.006_bib0190","first-page":"114","article-title":"Therapeutic effect and mechanism of Danhong injection on coronary heart disease","volume":"10","author":"Jin","year":"2018","journal-title":"Zhong Guo Ji Xu Yi Xue Jiao Yu"},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0195","first-page":"1661","article-title":"Clinical study on the clinical effects of Danhong injection combined with statins in the treatment of coronary atherosclerotic heart disease","volume":"29","author":"Yu","year":"2016","journal-title":"Shu Li Yi Yao Xue Za Zhi"},{"issue":"03","key":"10.1016\/j.phrs.2018.11.006_bib0200","first-page":"202","article-title":"Clinical study of Danhong injection in the treatment of coronary heart disease","volume":"35","author":"Wang","year":"2017","journal-title":"Si Chuan Zhong Yi"},{"issue":"07","key":"10.1016\/j.phrs.2018.11.006_bib0205","first-page":"1429","article-title":"Clinical efficacy of Danhong injection in the treatment of coronary heart disease complicated with diabetes","volume":"44","author":"Wang","year":"2017","journal-title":"Liao Ning Zhong Yi Za Zhi"},{"issue":"80","key":"10.1016\/j.phrs.2018.11.006_bib0210","article-title":"Clinical observation of Danhong injection in treating diabetes complicated with coronary heart disease and angina pectoris","volume":"17","author":"Fu","year":"2017","journal-title":"Shi Jie Zui Xin Yi Xue Xin Xi Wen Zhai"},{"issue":"06","key":"10.1016\/j.phrs.2018.11.006_bib0215","first-page":"754","article-title":"Treatment of 40 cases of coronary heart disease with heart failure by shenmai injection combined with Danhong injection","volume":"15","author":"Wang","year":"2017","journal-title":"Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi"},{"issue":"03","key":"10.1016\/j.phrs.2018.11.006_bib0220","first-page":"12","article-title":"Clinical observation on treatment of 80 cases of chronic heart failure with Danhong injection and western medicine","volume":"22","author":"Li","year":"2014","journal-title":"Zhong Guo Yi Xue Gong Cheng"},{"issue":"22","key":"10.1016\/j.phrs.2018.11.006_bib0225","first-page":"4","article-title":"Efficacy and safety of Danhong injection in the treatment of elderly patients with chronic heart failure","volume":"9","author":"Li","year":"2016","journal-title":"Lin Chuang He LI Yong Yao Za Zhi"},{"issue":"03","key":"10.1016\/j.phrs.2018.11.006_bib0230","first-page":"338","article-title":"Effect of ACEI combined with Danhong injection on chronic heart failure complicated with arrhythmia","volume":"15","author":"Liu","year":"2017","journal-title":"Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi"},{"issue":"02","key":"10.1016\/j.phrs.2018.11.006_bib0235","first-page":"40","article-title":"Clinical effect analysis of Danhong injection in treating angina pectoris of coronary heart disease","volume":"10","author":"Wang","year":"2018","journal-title":"Zhong Yi Lin Chuang Yan Jiu"},{"issue":"14","key":"10.1016\/j.phrs.2018.11.006_bib0240","first-page":"143","article-title":"Therapeutic effect of Danhong injection combined with puerarin injection on coronary heart disease with angina pectoris","volume":"12","author":"Li","year":"2016","journal-title":"Ya Tai Chuan Tong Yi Yao"},{"issue":"32","key":"10.1016\/j.phrs.2018.11.006_bib0245","first-page":"18","article-title":"Effect of Danhong injection on hemorheological parameters and electrocardiogram in patients with coronary heart disease and angina pectoris","volume":"2","author":"Jing","year":"2017","journal-title":"Lin Chuang Yi Xue Yan Jiu Yu Shi Jian"},{"issue":"04","key":"10.1016\/j.phrs.2018.11.006_bib0250","article-title":"Clinical observation of Danhong injection in treating angina pectoris of coronary heart disease","volume":"31","author":"Zhou","year":"2017","journal-title":"Zhongguo Xiao Yi"},{"issue":"29","key":"10.1016\/j.phrs.2018.11.006_bib0255","article-title":"Therapeutic effect of Danhong injection combined with nitrate drugs on coronary heart disease with angina pectoris","volume":"5","author":"Wang","year":"2017","journal-title":"Zhong Xi Yi Jie He Xin Xue Guan Bing Dian Zi Za Zhi"},{"key":"10.1016\/j.phrs.2018.11.006_bib0260","first-page":"42","article-title":"Danhong injection improves the treatment effect, adverse reactions and electrocardiogram of patients with angina pectoris","volume":"05","author":"Su","year":"2017","journal-title":"Xin Xue Guan Bing Fang Zhi Zhi Shi"},{"key":"10.1016\/j.phrs.2018.11.006_bib0265","article-title":"Clinical study of Danhong injection in treating angina pectoris of coronary heart disease","volume":"12","author":"Liu","year":"2006","journal-title":"Zhong Guo Yi Shi Za Zhi"},{"issue":"10","key":"10.1016\/j.phrs.2018.11.006_bib0270","first-page":"83","article-title":"Therapeutic effect of Danhong injection on 70 patients with coronary heart disease and angina pectoris","volume":"33","author":"Sun","year":"2017","journal-title":"Shi Jie Zui Xin Yi Xue Xin Xi Wen Zhai"},{"issue":"91","key":"10.1016\/j.phrs.2018.11.006_bib0275","article-title":"Application effect of atorvastatin combined with Danhong injection in the treatment of patients with angina pectoris","volume":"17","author":"Zhang","year":"2017","journal-title":"World Latest Med. Inf."},{"issue":"33","key":"10.1016\/j.phrs.2018.11.006_bib0280","article-title":"Clinical observation on 106 cases of unstable angina pectoris treated by Danhong injection","volume":"5","author":"Yang","year":"2017","journal-title":"Zhong Xi Yi Jie He Xin Xue Guan Bing Dian Zi Za Zhi"},{"issue":"05","key":"10.1016\/j.phrs.2018.11.006_bib0285","first-page":"123","article-title":"Clinical observation of Danhong injection combined with atorvastatin calcium in treating angina pectoris of coronary heart disease","volume":"6","author":"Wang","year":"2018","journal-title":"Zhong Xi Yi Jie He Xin Xue Guan Bing Dian Zi Za Zhi"},{"issue":"01","key":"10.1016\/j.phrs.2018.11.006_bib0290","first-page":"109","article-title":"Effect of Danhong injection combined with rosuvastatin on patients with unstable angina pectoris and its effect on serum TNF-\u03b1, hs-CRP and IL-6","volume":"21","author":"Lu","year":"2018","journal-title":"Zhong Guo Yao Shi"},{"issue":"01","key":"10.1016\/j.phrs.2018.11.006_bib0295","first-page":"32","article-title":"Clinical effect and adverse reactions of Danhong injection in patients with unstable angina pectoris","volume":"14","author":"Zhang","year":"2018","journal-title":"Shi Yong Tang Niao Bing Za Zhi"},{"issue":"03","key":"10.1016\/j.phrs.2018.11.006_bib0300","first-page":"127","article-title":"Effect of Danhong injection combined with metoprolol tartrate on ST segment changes of electrocardiogram and serum soluble intercellular adhesion molecule-1 and brain natriuretic peptide in patients with unstable angina pectoris","volume":"26","author":"Lin","year":"2018","journal-title":"Shi Yong Xin Nao Fei Xue Guan Bing Za Zhi"},{"issue":"13","key":"10.1016\/j.phrs.2018.11.006_bib0305","first-page":"1554","article-title":"Clinical efficacy of Danhong combined with rosuvastatin in the treatment of unstable angina pectoris and its effect on serum inflammatory factors and hemorheology","volume":"46","author":"Zhang","year":"2017","journal-title":"Shan Xi Yi Yao Za Zhi"},{"issue":"02","key":"10.1016\/j.phrs.2018.11.006_bib0310","article-title":"Clinical efficacy of Danhong injection combined with rosuvastatin in the treatment of unstable angina pectoris","volume":"15","author":"Wang","year":"2018","journal-title":"Zhong Guo He Li Yong Yao Tan Suo"},{"issue":"10","key":"10.1016\/j.phrs.2018.11.006_bib0315","first-page":"118","article-title":"Clinical observation on treatment of unstable angina pectoris with Danhong injection and kelinao","volume":"34","author":"Lv","year":"2018","journal-title":"Zhong Guo She Qu Yi Shi"},{"issue":"22","key":"10.1016\/j.phrs.2018.11.006_bib0320","first-page":"46","article-title":"Effect of Danhong injection on plasma hcy and MMP-2 levels in elderly patients with unstable angina pectoris","volume":"56","author":"Yin","year":"2016","journal-title":"Shan Dong Yi Yao"},{"issue":"08","key":"10.1016\/j.phrs.2018.11.006_bib0325","first-page":"12","article-title":"Therapeutic effect of Danhong injection combined with Naoxintong Capsule on unstable angina pectoris","volume":"36","author":"Dong","year":"2017","journal-title":"Nei Meng Gu Zhong Yi Yao"},{"issue":"09","key":"10.1016\/j.phrs.2018.11.006_bib0330","first-page":"1616","article-title":"Clinical observation of Danhong injection combined with low molecular weight heparin in the treatment of elderly patients with acute coronary syndrome","volume":"27","author":"Wang","year":"2016","journal-title":"Xian Dai Zhen Duan Yu Zhi Liao"},{"issue":"07","key":"10.1016\/j.phrs.2018.11.006_bib0335","first-page":"894","article-title":"Effect of Danhong injection combined with clopidogrel hydrochloride tablet on serum inflammatory factors, platelet activation and vascular endothelial function in patients with acute coronary syndrome","volume":"23","author":"Zhang","year":"2017","journal-title":"Hai Nan Yi Xue Yuan Xue Bao"},{"issue":"15","key":"10.1016\/j.phrs.2018.11.006_bib0340","first-page":"1619","article-title":"Effect of Danhong injection on endothelial injury, inflammatory response and cardiac function in patients with acute coronary syndrome after interventional therapy","volume":"22","author":"Liu","year":"2016","journal-title":"Hai Nan Yi Xue Yuan Xue Bao"},{"issue":"21","key":"10.1016\/j.phrs.2018.11.006_bib0345","first-page":"29","article-title":"Therapeutic effect of Danhong injection combined with tirofiban hydrochloride in patients with acute coronary syndrome","volume":"21","author":"Wang","year":"2017","journal-title":"Shi Yong Lin Chuang Yi Yao Za Zhi"},{"issue":"26","key":"10.1016\/j.phrs.2018.11.006_bib0350","first-page":"5122","article-title":"Effect of Danhong injection on plasma brain natriuretic peptide and heart rate variability in patients with acute coronary syndrome","volume":"15","author":"Liu","year":"2015","journal-title":"Xian Dai Sheng Wu Yi Xue Jin Zhan"},{"issue":"20","key":"10.1016\/j.phrs.2018.11.006_bib0355","first-page":"49","article-title":"Effect of Danhong injection combined with high-dose atorvastatin on blood lipid, hs-CRP and TNF-\u03b1 in patients with acute coronary syndrome after interventional therapy","volume":"21","author":"Qiao","year":"2015","journal-title":"Zhong Yi Yao Dao Bao"},{"issue":"10","key":"10.1016\/j.phrs.2018.11.006_bib0360","first-page":"1328","article-title":"Therapeutic effect of Danhong injection on elderly patients with acute coronary syndrome","volume":"19","author":"Li","year":"2015","journal-title":"Ji Ceng Yi Xue Lun Tan"},{"issue":"06","key":"10.1016\/j.phrs.2018.11.006_bib0365","first-page":"148","article-title":"Effect of Danhong injection combined with clopidogrel on serum endothelin and nitric oxide levels after percutaneous coronary intervention therapy in patients with acute coronary syndrome","volume":"25","author":"Ye","year":"2017","journal-title":"Shi Yong Xin Nao Fei Xue Guan Bing Za Zhi"},{"issue":"12","key":"10.1016\/j.phrs.2018.11.006_bib0370","first-page":"63","article-title":"Effect of Danhong injection combined with irbesartan on blood pressure control and serum GSH-Px level in patients with essential hypertension","volume":"14","author":"Fu","year":"2017","journal-title":"Bei Fang Yao xue"},{"issue":"07","key":"10.1016\/j.phrs.2018.11.006_bib0375","first-page":"37","article-title":"Effect of Danhong injection combined with felodipine on vascular endothelial function and quality of life in patients with essential hypertension","volume":"15","author":"Dai","year":"2018","journal-title":"Bei Fang Yao xue"},{"issue":"04","key":"10.1016\/j.phrs.2018.11.006_bib0380","first-page":"458","article-title":"Effects of Danhong injection on vascular endothelial function, inflammation index and amino terminal brain natriuretic peptide precursor in patients with essential hypertension","volume":"39","author":"Li","year":"2018","journal-title":"Shan Xi Zhong Yi"},{"issue":"02","key":"10.1016\/j.phrs.2018.11.006_bib0385","first-page":"297","article-title":"Effect of Danhong injection combined with folic acid tablet on human plasma homocysteine in patients with hyperhomocysteinemia hypertension","volume":"44","author":"Huo","year":"2017","journal-title":"Liao Ning zhong yi Za Zhi"},{"issue":"4","key":"10.1016\/j.phrs.2018.11.006_bib0390","doi-asserted-by":"crossref","first-page":"16929","DOI":"10.4238\/2015.December.14.21","article-title":"Effects of Danhong injection on hemodynamics and the inflammation-related NF-kappaB signaling pathway in patients with acute cerebral infarction","volume":"14","author":"Jiang","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"01","key":"10.1016\/j.phrs.2018.11.006_bib0395","first-page":"18","article-title":"Clinical study of Danhong injection on cerebral infarction of branch atherosclerosis","volume":"18","author":"Tan","year":"2016","journal-title":"ShenYang Yi Xue Yuan Xue Bao"},{"issue":"7","key":"10.1016\/j.phrs.2018.11.006_bib0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071355","article-title":"In-depth proteomic analysis of the Hippocampus in a rat model after cerebral ischaemic injury and repair by Danhong injection (DHI)","volume":"18","author":"Cui","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2018.11.006_bib0405","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.phrs.2018.07.020","article-title":"Dose-dependent target diversion of Danhong injection on the Glu-GLT-1\/Gly-GlyRalpha dynamic balance module of cerebral ischemia","volume":"135","author":"Xu","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.phrs.2018.11.006_bib0410","first-page":"564","article-title":"NRF2 and cancer: the good, the bad and the importance of context, Nature reviews","volume":"12","author":"Sporn","year":"2012","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2018.11.006_bib0415","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s11064-014-1384-1","article-title":"Danhong injection attenuates ischemia\/reperfusion-induced brain damage which is associating with Nrf2 levels in vivo and in vitro","volume":"39","author":"Guo","year":"2014","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.006_bib0420","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11883-012-0227-2","article-title":"Diabetes and hypertension: is there a common metabolic pathway?","volume":"14","author":"Cheung","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2018.11.006_bib0425","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/aps.2014.167","article-title":"DanHong injection dose-dependently varies amino acid metabolites and metabolic pathways in the treatment of rats with cerebral ischemia","volume":"36","author":"Guo","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2018.11.006_bib0430","doi-asserted-by":"crossref","first-page":"29823","DOI":"10.1038\/srep29823","article-title":"Systematic investigation of transcription factors critical in the protection against cerebral ischemia by Danhong injection","volume":"6","author":"Wei","year":"2016","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.phrs.2018.11.006_bib0435","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4103\/1673-5374.139462","article-title":"Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury","volume":"9","author":"Wang","year":"2014","journal-title":"Neural Regen. Res."},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0440","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s11064-007-9382-1","article-title":"Morphological alteration of Golgi apparatus and subcellular compartmentalization of TGF-beta1 in Golgi apparatus in gerbils following transient forebrain ischemia","volume":"32","author":"Hu","year":"2007","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.phrs.2018.11.006_bib0445","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12640-009-9117-y","article-title":"The role of integrin alpha(v)beta (8) in neonatal hypoxic-ischemic brain injury","volume":"17","author":"Li","year":"2010","journal-title":"Neurotox. Res."},{"issue":"25","key":"10.1016\/j.phrs.2018.11.006_bib0450","first-page":"2343","article-title":"Danhong injection: a modulator for Golgi structural stability after cerebral ischemia-reperfusion injury","volume":"8","author":"Wang","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2018.11.006_bib0455","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2011.00024","article-title":"Prostacyclin: an inflammatory paradox","volume":"2","author":"Stitham","year":"2011","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.006_bib0460","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jep.2012.09.025","article-title":"Protective effect of Danhong injection on cerebral ischemia-reperfusion injury in rats","volume":"144","author":"He","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"22","key":"10.1016\/j.phrs.2018.11.006_bib0465","first-page":"4399","article-title":"[Protective effect of combined administration of active ingredients of Danhong on cerebral micro-vascular endothelial cell injured by hypoxia]","volume":"39","author":"Zhou","year":"2014","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"24","key":"10.1016\/j.phrs.2018.11.006_bib0470","first-page":"4844","article-title":"[Protective mechanism of Danhong injection on brain microvascular endothelial cells injured by hypoxic]","volume":"39","author":"Zhou","year":"2014","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.phrs.2018.11.006_bib0475","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jep.2017.10.002","article-title":"Protective effect of Danhong Injection combined with Naoxintong Capsule on cerebral ischemia-reperfusion injury in rats","volume":"211","author":"Wan","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"5 Suppl","key":"10.1016\/j.phrs.2018.11.006_bib0480","first-page":"1699","article-title":"The index and improvement effect of using Danhong injection to patients with atherosclerosis symptoms of coronary heart disease (CHD)","volume":"27","author":"Sun","year":"2014","journal-title":"Pak. J. Pharm. Sci."},{"issue":"30","key":"10.1016\/j.phrs.2018.11.006_bib0485","first-page":"2346","article-title":"[Myocardial protective effect of Danhong Injection evaluated by velocity vector imaging in patients undergoing percutaneous coronary intervention]","volume":"94","author":"Dong","year":"2014","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0490","first-page":"11","article-title":"[Effect of Danhong injection on ET-1, sP-sel, and hs-CRP in patients with acute coronary syndrome undergoing percutaneous coronary intervention]","volume":"31","author":"Zhao","year":"2011","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"4","key":"10.1016\/j.phrs.2018.11.006_bib0495","first-page":"301","article-title":"Effect of Danhong injection combined with naoxintong tablets on prognosis and inflammatory factor expression in acute coronary syndrome patients undergoing percutaneous coronary intervention","volume":"31","author":"Lv","year":"2015","journal-title":"Acta Cardiol. Sin."},{"issue":"8","key":"10.1016\/j.phrs.2018.11.006_bib0500","first-page":"692","article-title":"Effect of Danhong injection on platelet activation and inflammatory factors in patients of acute coronary syndrome after intervention therapy","volume":"29","author":"Chen","year":"2009","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"2013","key":"10.1016\/j.phrs.2018.11.006_bib0505","article-title":"Dissection of mechanisms of a chinese medicinal formula: Danhong injection therapy for myocardial ischemia\/reperfusion injury in vivo and in vitro","author":"Guan","year":"2013","journal-title":"Evid. Based Complement. Altern. Med.: eCAM"},{"issue":"6","key":"10.1016\/j.phrs.2018.11.006_bib0510","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11655-010-0567-0","article-title":"Synergistic protection of Danhong injection (\u4e39\u7ea2\u6ce8\u5c04\u6db2) and ischemic postconditioning on myocardial reperfusion injury in minipigs","volume":"16","author":"Ma","year":"2010","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phrs.2018.11.006_bib0515","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jep.2016.10.025","article-title":"Amelioration of cardiac dysfunction and ventricular remodeling after myocardial infarction by Danhong injection are critically contributed by anti-TGF-beta-mediated fibrosis and angiogenesis mechanisms","volume":"194","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2018.11.006_bib0520","first-page":"1463","article-title":"[Protective effect of injection of Danhong against acute myocardial ischemia in dogs]","volume":"33","author":"Guo","year":"2008","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.phrs.2018.11.006_bib0525","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fphys.2018.00991","article-title":"Danhong injection enhances the therapeutic efficacy of mesenchymal stem cells in myocardial infarction by promoting angiogenesis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2018.11.006_bib0530","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3389\/fphar.2018.00692","article-title":"Danhong injection reversed cardiac abnormality in brain-heart syndrome via local and remote beta-adrenergic receptor signaling","volume":"9","author":"Orgah","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2018.11.006_bib0535","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jpba.2018.02.012","article-title":"Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: insight by LC-MS based non-targeted metabolomic analysis","volume":"152","author":"Yi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phrs.2018.11.006_bib0540","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jep.2015.08.033","article-title":"Danhong injection protects cardiomyocytes against hypoxia\/reoxygenation- and H2O2-induced injury by inhibiting mitochondrial permeability transition pore opening","volume":"175","author":"Duan","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"24","key":"10.1016\/j.phrs.2018.11.006_bib0545","first-page":"4905","article-title":"[Establishment pharmacological research platform for \"Concurrent treatment of the brain and heart\" and its application on dissecting mechanism of Danhong injection]","volume":"42","author":"Zhao","year":"2017","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0550","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/FJC.0000000000000164","article-title":"Vasorelaxant activities of Danhong injection and their differential effects on the rat abdominal aorta and mesenteric artery","volume":"65","author":"Su","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"17","key":"10.1016\/j.phrs.2018.11.006_bib0555","first-page":"2607","article-title":"[Effect and mechanism of Danhong injection on isolated mesenteric arterial rings in rats]","volume":"37","author":"Zhi","year":"2012","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"5","key":"10.1016\/j.phrs.2018.11.006_bib0560","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/FJC.0b013e3182a29657","article-title":"Vascular reactivity screen of Chinese medicine Danhong injection identifies Danshensu as a NO-independent but PGI2-mediated relaxation factor","volume":"62","author":"Wang","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2018.11.006_bib0565","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/BC.2006.085","article-title":"The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction","volume":"387","author":"Chao","year":"2006","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2018.11.006_bib0570","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/hsz-2012-0332","article-title":"Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency","volume":"394","author":"Potier","year":"2013","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0575","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1038\/s41598-017-04661-1","article-title":"Danhong injection reduces vascular remodeling and up-regulates the Kallikrein-kinin system in spontaneously hypertensive rats","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0580","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000486735","article-title":"Danhong injection protects against hypertension-induced renal injury via down-regulation of myoglobin expression in spontaneously hypertensive rats","volume":"43","author":"Owoicho Orgah","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"4","key":"10.1016\/j.phrs.2018.11.006_bib0585","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11655-016-2498-x","article-title":"Effects of Danhong Injection (\u4e39\u7ea2\u6ce8\u5c04\u6db2) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells","volume":"22","author":"Zhang","year":"2016","journal-title":"Chin. J. Integr. Med."},{"issue":"61","key":"10.1016\/j.phrs.2018.11.006_bib0590","doi-asserted-by":"crossref","first-page":"103393","DOI":"10.18632\/oncotarget.21900","article-title":"DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2018.11.006_bib0595","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jep.2016.03.015","article-title":"Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-kappab pathway","volume":"186","author":"Mao","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2018.11.006_bib0600","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.brainres.2016.04.046","article-title":"Danhong injection attenuates cardiac injury induced by ischemic and reperfused neuronal cells through regulating arginine vasopressin expression and secretion","volume":"1642","author":"Yang","year":"2016","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.phrs.2018.11.006_bib0605","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/FJC.0000000000000067","article-title":"Danhong injection inhibits the development of atherosclerosis in both Apoe(-)\/(-) and Ldlr(-)\/(-) mice","volume":"63","author":"Chen","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0610","first-page":"1720","article-title":"[Effects of Danhong injection on experimental atherosclerosis rabbit model and its mechanism]","volume":"32","author":"Fu","year":"2009","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.phrs.2018.11.006_bib0615","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2017.10.017","article-title":"Effects of Danhong Injection on platelet aggregation in hyperlipidemia rats","volume":"212","author":"Fan","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.11226FP","article-title":"Danhong inhibits oxidized low-density lipoprotein-induced immune maturation of dentritic cells via a peroxisome proliferator activated receptor gamma-mediated pathway","volume":"119","author":"Liu","year":"2012","journal-title":"J. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2018.11.006_bib0625","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0254-6272(13)60183-1","article-title":"Effect of Danhong injection on expressions of macrophage scavenger receptor 1 and sub-family A member 1 in human U937 cells","volume":"33","author":"Su","year":"2013","journal-title":"J. Tradit. Chin. Med."},{"issue":"10","key":"10.1016\/j.phrs.2018.11.006_bib0630","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/aps.2010.167","article-title":"Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia","volume":"31","author":"Yang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.006_bib0635","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1742-7843.2008.00342.x","article-title":"Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells","volume":"104","author":"Yang","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0640","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.intimp.2005.05.005","article-title":"Aqueous extract of Salvia miltiorrhiza attenuates increased endothelial permeability induced by tumor necrosis factor-alpha","volume":"5","author":"Ding","year":"2005","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.006_bib0645","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2009.08.045","article-title":"Proliferative inhibition of danxiongfang and its active ingredients on rat vascular smooth muscle cell and protective effect on the VSMC damage induced by hydrogen peroxide","volume":"126","author":"Wu","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2018.11.006_bib0650","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11745-016-4178-1","article-title":"Danshensu promotes cholesterol efflux in RAW264.7 macrophages","volume":"51","author":"Gao","year":"2016","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.phrs.2018.11.006_bib0655","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/FJC.0000000000000117","article-title":"Salvianolic acid A suppresses CCL-20 expression in TNF-alpha-treated macrophages and ApoE-deficient mice","volume":"64","author":"Zhang","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2018.11.006_bib0660","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.phymed.2014.05.003","article-title":"Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice","volume":"21","author":"Zhang","year":"2014","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.phrs.2018.11.006_bib0665","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.3390\/molecules17033333","article-title":"Salvianolic acid A inhibits PDGF-BB induced vascular smooth muscle cell migration and proliferation while does not constrain endothelial cell proliferation and nitric oxide biosynthesis","volume":"17","author":"Sun","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2018.11.006_bib0670","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2016.01.015","article-title":"Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: an insight from a plant polyphenol","volume":"103","author":"Sun","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0675","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.intimp.2011.07.022","article-title":"Salvianolic acid A suppress lipopolysaccharide-induced NF-kappaB signaling pathway by targeting IKKbeta","volume":"11","author":"Oh","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2018.11.006_bib0680","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/cpr.12056","article-title":"In silico analysis and experimental validation of molecular mechanisms of salvianolic acid A-inhibited LPS-stimulated inflammation, in RAW264.7 macrophages","volume":"46","author":"Huang","year":"2013","journal-title":"Cell Prolif."},{"issue":"26","key":"10.1016\/j.phrs.2018.11.006_bib0685","doi-asserted-by":"crossref","DOI":"10.2174\/0929867321666140601195940","article-title":"Salvianolic acid B inhibits atherogenesis of vascular cells through induction of Nrf2-dependent heme oxygenase-1","volume":"21","author":"Lee","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2018.11.006_bib0690","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/aps.2009.122","article-title":"Inhibitory effects of lithospermic acid on proliferation and migration of rat vascular smooth muscle cells","volume":"30","author":"Chen","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0695","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2174\/092986712799945067","article-title":"Nonmuscle myosin heavy chain and histone H3 are intracellular binding partners of lithospermic acid B and mediate its antiproliferative effect on VSMCs","volume":"19","author":"Cho","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2018.11.006_bib0700","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2015.04.122","article-title":"Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux by targeting PPAR-gamma and LXRalpha","volume":"462","author":"Yue","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0705","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.atherosclerosis.2012.05.006","article-title":"Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner","volume":"223","author":"Bao","year":"2012","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.phrs.2018.11.006_bib0710","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/ptr.3720","article-title":"Protocatechuic aldehyde inhibits lipopolysaccharide-induced human umbilical vein endothelial cell apoptosis via regulation of caspase-3","volume":"26","author":"Xing","year":"2012","journal-title":"Phytother. Res.: PTR"},{"issue":"3","key":"10.1016\/j.phrs.2018.11.006_bib0715","doi-asserted-by":"crossref","first-page":"e0149394","DOI":"10.1371\/journal.pone.0149394","article-title":"Vasculoprotective effects of 3-Hydroxybenzaldehyde against VSMCs proliferation and ECs inflammation","volume":"11","author":"Kong","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0720","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/etm.2015.2896","article-title":"Protocatechuic aldehyde inhibits TNF-alpha-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway","volume":"11","author":"Tong","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"22","key":"10.1016\/j.phrs.2018.11.006_bib0725","doi-asserted-by":"crossref","first-page":"e7079","DOI":"10.1097\/MD.0000000000007079","article-title":"A comparative study of Danhong injection and Salvia miltiorrhiza injection in the treatment of cerebral infarction: a systematic review and meta-analysis","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0730","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12944-018-0760-2","article-title":"The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials","volume":"17","author":"Yu","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"32","key":"10.1016\/j.phrs.2018.11.006_bib0735","first-page":"30","article-title":"Evaluation of the economic effects of different treatment regimens in the treatment of cerebral infarction","volume":"8","author":"Yan","year":"2015","journal-title":"Lin Chuang He Li Yong Yao Za Zhi"},{"issue":"18","key":"10.1016\/j.phrs.2018.11.006_bib0740","first-page":"3462","article-title":"[Analysis of traditional Chinese medicine syndrome, traditional Chinese medicine and western medicine in 84 697 patients with coronary heart disease based on big data]","volume":"39","author":"Li","year":"2014","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"4","key":"10.1016\/j.phrs.2018.11.006_bib0745","first-page":"748","article-title":"Rationality analysis of clinical application of Danhong injection in affiliated hospital of Nanjing university of Chinese medicine from 2013 to 2014","volume":"41","author":"Zhang","year":"2016","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"20","key":"10.1016\/j.phrs.2018.11.006_bib0750","first-page":"2783","article-title":"[Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital]","volume":"36","author":"Li","year":"2011","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"2","key":"10.1016\/j.phrs.2018.11.006_bib0755","first-page":"242","article-title":"Literature analysis of adverse reactions of Danhong injection from 2005 to 2015","volume":"31","author":"Tan","year":"2016","journal-title":"Xian Dai Yao Wu Yu Lin Chuang"},{"key":"10.1016\/j.phrs.2018.11.006_bib0760","unstructured":"S. Cao, J. Li, W.f. Li, Adverse reactions and rational application of Danhong injection, Ha Er Bin Yi Yao (6) (2014) 386-387."},{"issue":"17","key":"10.1016\/j.phrs.2018.11.006_bib0765","first-page":"2352","article-title":"Literature analysis of 360 cases of adverse reactions of Danhong injection","volume":"27","author":"Wang","year":"2016","journal-title":"Zhong Guo Yao Fang"},{"issue":"11","key":"10.1016\/j.phrs.2018.11.006_bib0770","first-page":"763","article-title":"Statistical analysis of the national report on national adverse drug reaction monitoring 2013-2016","volume":"26","author":"Zhang","year":"2017","journal-title":"Yao Wu Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.phrs.2018.11.006_bib0775","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-018-2468-7","article-title":"Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles","author":"Lin","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2018.11.006_bib0780","first-page":"974","article-title":"Genetic signatures in ischemic stroke: focus on aspirin resistance","volume":"16","author":"Vasudeva","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2018.11.006_bib0785","doi-asserted-by":"crossref","DOI":"10.1038\/s41397-018-0018-4","article-title":"Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy","author":"Wu","year":"2018","journal-title":"Pharmacogenomics J."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.006_bib0790","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jep.2013.10.050","article-title":"Towards a better understanding of medicinal uses of Carthamus tinctorius L. In traditional Chinese medicine: a phytochemical and pharmacological review","volume":"151","author":"Zhou","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2018.11.006_bib0795","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jep.2014.07.058","article-title":"Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs","volume":"155","author":"Guo","year":"2014","journal-title":"J. Ethnopharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818308569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818308569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:55:14Z","timestamp":1760910914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818308569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":159,"alternative-id":["S1043661818308569"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.11.006","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}